161 related articles for article (PubMed ID: 19322578)
1. Comparison of acquired cholesteatoma between pediatric and adult patients.
Dornelles Cde C; da Costa SS; Meurer L; Rosito LP; da Silva AR; Alves SL
Eur Arch Otorhinolaryngol; 2009 Oct; 266(10):1553-61. PubMed ID: 19322578
[TBL] [Abstract][Full Text] [Related]
2. Histologic description of acquired cholesteatomas: comparison between children and adults.
Dornelles C; Meurer L; Selaimen da Costa S; Schweiger C
Braz J Otorhinolaryngol; 2006; 72(5):641-8. PubMed ID: 17221056
[TBL] [Abstract][Full Text] [Related]
3. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
4. Correlation of cholesteatomas perimatrix thickness with patient's age.
Dornelles C; da Costa SS; Meurer L; Schweiger C
Braz J Otorhinolaryngol; 2005; 71(6):792-7. PubMed ID: 16878250
[TBL] [Abstract][Full Text] [Related]
5. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Choufani G; Ghanooni R; Decaestecker C; Delbrouck K; Simon P; Schüring MP; Zick Y; Hassid S; Gabius HJ; Kiss R
Laryngoscope; 2001 Sep; 111(9):1656-62. PubMed ID: 11568623
[TBL] [Abstract][Full Text] [Related]
6. [Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma].
Milewski C; Fedorowski A; Stan AC; Walter GF
HNO; 1998 Sep; 46(9):804-8. PubMed ID: 9816534
[TBL] [Abstract][Full Text] [Related]
7. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
Wang H; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 2: an important genetic marker for cholesteatomas.
Morales DS; Penido Nde O; da Silva ID; Stávale JN; Guilherme A; Fukuda Y
Braz J Otorhinolaryngol; 2007; 73(1):51-7. PubMed ID: 17505599
[TBL] [Abstract][Full Text] [Related]
10. Hystology findings' correlation between the ossicular chain in the transoperative and cholesteatomas.
Dornelles C; Schmidt Rosito LP; Meurer L; da Costa SS; Argenta A; Alves SL
Braz J Otorhinolaryngol; 2007; 73(6):738-743. PubMed ID: 18278219
[TBL] [Abstract][Full Text] [Related]
11. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
Ayache S; Tramier B; Strunski V
Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
[TBL] [Abstract][Full Text] [Related]
12. [Acquired pediatric cholesteatoma: predictive factors of recurrence. A retrospective study of 11 years].
Farah C; Rouhayem Z; Nassif C; Rassi S
J Med Liban; 2014; 62(1):7-13. PubMed ID: 24684120
[TBL] [Abstract][Full Text] [Related]
13. Analysis of histopathological aspects in acquired middle ear cholesteatoma.
Alves AL; Pereira CSB; Ribeiro FAQ; Fregnani JHTG
Braz J Otorhinolaryngol; 2008; 74(6):835-841. PubMed ID: 19582339
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological features of cholesteatoma in young children].
Skotnicka B; Hassmann-Poznańska E
Otolaryngol Pol; 2010; 64(6):375-81. PubMed ID: 21302505
[TBL] [Abstract][Full Text] [Related]
15. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
Durko M; Kaczmarczyk D
Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
[TBL] [Abstract][Full Text] [Related]
16. Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.
Kan T; Ueda H; Takahara T; Tsuchiya Y; Kishimoto M; Uchida Y; Ogawa T; Ohashi W; Tsuzuki T; Fujimoto Y
Biomed Res Int; 2021; 2021():6644897. PubMed ID: 33778077
[TBL] [Abstract][Full Text] [Related]
17. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
[TBL] [Abstract][Full Text] [Related]
18. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
Welkoborsky HJ
Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
[TBL] [Abstract][Full Text] [Related]
19. [Immunomorphological evaluation of cholesteatoma].
Kuczkowski J; Bakowska A; Mikaszewski B
Otolaryngol Pol; 2004; 58(2):289-95. PubMed ID: 15307474
[TBL] [Abstract][Full Text] [Related]
20. Perimatrix of middle ear cholesteatoma: A granulation tissue with a specific transcriptomic signature.
Jovanovic I; Zivkovic M; Djuric T; Stojkovic L; Jesic S; Stankovic A
Laryngoscope; 2020 Apr; 130(4):E220-E227. PubMed ID: 31132150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
